Cargando…

Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease

Osteoprotegerin (OPG) regulates bone mass by inhibiting osteoclast differentiation and activation, and plays a role in vascular calcification. We evaluated the relationship between osteoprotegerin levels and inflammatory markers, atherosclerosis, and mortality in patients with stages 3-5 chronic kid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nascimento, M.M., Hayashi, S.Y., Riella, M.C., Lindholm, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2014
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230291/ https://www.ncbi.nlm.nih.gov/pubmed/25296363 http://dx.doi.org/10.1590/1414-431X20144007

Ejemplares similares

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
por: Marques, Gustavo Lenci, et al.
Publicado: (2021)

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
por: Kamińska, Joanna, et al.
Publicado: (2021)

Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function
por: Collado, Sílvia, et al.
Publicado: (2017)

Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women
por: Lewis, Joshua R., et al.
Publicado: (2015)

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
por: Poulsen, Mikael K, et al.
Publicado: (2011)

Marked Elevation in Plasma Osteoprotegerin Constitutes an Early and Consistent Feature of Cerebral Malaria
por: O’Regan, Niamh, et al.
Publicado: (2016)

Circulating Osteoprotegerin Levels Independently Predict All-cause Mortality in Patients with Chronic Kidney Disease: a Meta-analysis
por: Huang, Qing-xiu, et al.
Publicado: (2019)

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
por: Augoulea, Areti, et al.
Publicado: (2013)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
por: Chen, Weena JY, et al.
Publicado: (2011)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
por: Reinhard, Henrik, et al.
Publicado: (2011)

Association of Plasma Concentration of Vitamin B(12) With All-Cause Mortality in the General Population in the Netherlands
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
por: Aoki, Atsushi, et al.
Publicado: (2013)

Osteoprotegerin and Mortality in Type 2 Diabetic Patients
por: Reinhard, Henrik, et al.
Publicado: (2010)

Clinically unrecognized plasma volume expansion predicts long‐term all‐cause‐mortality in chronic heart failure
por: Ahlgrim, Christoph, et al.
Publicado: (2022)

Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population
por: Sabanayagam, Charumathi, et al.
Publicado: (2019)

Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population
por: Cazarín-Santos, Benny Giovanni, et al.
Publicado: (2022)

Association of Extreme Heat With All-Cause Mortality in the Contiguous US, 2008-2017
por: Khatana, Sameed Ahmed M., et al.
Publicado: (2022)

Excess All-Cause Mortality in China After Ending the Zero COVID Policy
por: Xiao, Hong, et al.
Publicado: (2023)

Association of Intellectual Disability With All-Cause and Cause-Specific Mortality in Sweden
por: Hirvikoski, Tatja, et al.
Publicado: (2021)

Educational Attainment and Lifestyle Risk Factors Associated With All-Cause Mortality in the US
por: Puka, Klajdi, et al.
Publicado: (2022)

Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin
por: D'Abramo, Alessandra, et al.
Publicado: (2013)

Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
por: Miselli, Maria-Agata, et al.
Publicado: (2014)

Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
por: Nishimura, Masami, et al.
Publicado: (2019)

Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia
por: Feigin, Eugene, et al.
Publicado: (2023)

Association Between Receipt of Cancer Screening and All-Cause Mortality in Older Adults
por: Schoenborn, Nancy L., et al.
Publicado: (2021)

Variability of Serum Phosphate in Incident Hemodialysis Patients: Association with All-Cause Mortality
por: ter Meulen, Karlien J., et al.
Publicado: (2023)

Associations of Change in Body Size With All-Cause and Cause-Specific Mortality Among Healthy Older Adults
por: Hussain, Sultana Monira, et al.
Publicado: (2023)

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study
por: Chevli, Parag Anilkumar, et al.
Publicado: (2021)

Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease
por: Chuang, Mei-hsing, et al.
Publicado: (2017)

Evaluation of Dietary Patterns and All-Cause Mortality: A Systematic Review
por: English, Laural K., et al.
Publicado: (2021)

Association of Allostatic Load With All-Cause Mortality in Patients With Breast Cancer
por: Obeng-Gyasi, Samilia, et al.
Publicado: (2023)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
por: D'Abramo, Alessandra, et al.
Publicado: (2014)

Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
por: Pateinakis, Panagiotis, et al.
Publicado: (2013)

Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis
por: Ávila, Marcela, et al.
Publicado: (2022)

Association of Chronic Condition Special Needs Plan With Hospitalization and Mortality Among Patients With End-Stage Kidney Disease
por: Becker, Bryan N., et al.
Publicado: (2020)

Association of Weight Loss Between Early Adulthood and Midlife With All-Cause Mortality Risk in the US
por: Xie, Wubin, et al.
Publicado: (2020)

Association of Positive Affect Instability With All-Cause Mortality in Older Adults in England
por: Ong, Anthony D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2ppa0t6oidnua1p7u6sof2sv5v